Cough Variant Asthma
Conditions
Interventions
Treatment group:Sangxingzhike granules+montelukast sodium tablets
Control group:Sangxingzhike granules Placebo+montelukast sodium tablets
Sponsors
Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets the Western medical diagnostic criteria for cough variant asthma; (2) Meets the diagnostic criteria for the TCM syndrome of dry pathogen invading the lung in cough; (3) Age range: 18 - 75 years old (including 18 years old, but excluding 75 years old), gender not restricted; (4) Voluntarily participate in this trial and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: (1) Including fever, lung infection, acute pharyngitis, etc.; (2) Having other primary diseases in organs other than the lungs; (3) Cognitive impairment or mental abnormalities. (4) Pregnant or lactating women, or those allergic to this drug. (5) Patients who have recently taken drugs that may cause coughing, such as ACEI class antihypertensive drugs. (6) Those with poor compliance and who arbitrarily change the treatment plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement rate of total efficacy score for TCM syndromes; | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reactive protein;Liver function;Kidney function;TCM syndrome score;Cough symptom score;Visual analog score;Lycester cough Quality of Life Questionnaire;Cough severity score;lung function;blood routine examination; | — |
Countries
China
Contacts
Public ContactLi Fengsen
Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine
Outcome results
None listed